Skip to main content
Home
Explore
Notifs
Profile

Black-owned · Built for the global diaspora · Curated pins from Black and melanated creators across hair, style, beauty, home, and art.

Formerly Melaninterest.com

m
melanin
AboutHelpTermsPrivacyCommunity GuidelinesCreators

© 2026 Melanin. All rights reserved.

Mmelanin
HomeExploreCreatorsNewsCreate
Ctrl+K
Log inSign up
Mmelanin
HomeExploreCreatorsNewsCreate
Ctrl+K
Log inSign up
New Norovirus Strain Fuels Record Outbreaks Across U.S., Europe — Melanin News | Melanin
Mmelanin
HomeExploreCreatorsNewsCreate
Ctrl+K
Log inSign up
All news
New Norovirus Strain Fuels Record Outbreaks Across U.S., EuropeCulture

New Norovirus Strain Fuels Record Outbreaks Across U.S., Europe

5d ago

Norovirus, the highly contagious stomach bug known for its rapid spread, is making headlines with a new, formidable variant. This latest strain, identified as GII.17, has largely circumvented existing immunity, triggering a wave of outbreaks that have reached record levels across the United States and parts of Europe.

The situation marks a significant shift from typical norovirus activity. Reports indicate that GII.17 is now responsible for roughly 75% of current outbreaks, defying the usual seasonal patterns and extending its reach well into the spring months. Public health data shows this variant began to gain traction in April 2024, with increasing detections noted first in the U.S. and then across various European countries.

Norovirus
Norovirus Source

The 2023-2024 season saw GII.17 account for 34.3% of all outbreaks, notably surpassing the long-dominant GII.4 strain, which was responsible for 27.7%. The new strain's influence continued to grow, with GII.17 outbreaks consistently outnumbering GII.4 from May 2024 through March 2025. The 2024-2025 norovirus season kicked off earlier than usual in October 2024, a change attributed to the emergence and rapid spread of the GII.17 variant.

The United States experienced a record wave of illness during the 2024-2025 season. A staggering 1,078 norovirus outbreaks were reported between August 2024 and mid-January 2025, nearly doubling the 557 outbreaks reported during the same period the previous year. Late 2024 saw the U.S. register more suspected norovirus outbreaks in a single week than in any week over the preceding decade. Similarly, England reported over 9,000 lab-confirmed norovirus cases by February 2025, a figure that more than doubled the five-year seasonal average.

By December 2025, norovirus cases were surging ahead of schedule in the U.S., with approximately 13% of tests returning positive during the week ending November 15, a significant jump from three months prior. Wastewater surveillance in L.A. County indicated rising norovirus concentrations, mirroring a national trend where wastewater concentrations had increased by 69% since October 2025. The 2025-2026 season also began with an early rise in activity during the fall, peaking in early February 2026 with 72 outbreaks reported in states participating in the NoroSTAT surveillance system during the week of February 6, 2026. While some specific reports for the 2025-2026 season initially showed GII.4 as predominant in certain periods, the most recent data as of May 29, 2026, confirms GII.17 is fueling the majority of current outbreaks, accounting for approximately 75% during the most recent season.

Public health
Public health Source

Public health experts have weighed in on the unprecedented situation. Dr. Jan Vinjé, who heads the CDC's CaliciNet system, a crucial network for norovirus outbreak surveillance, commented on the early surge. He stated that it is "too early to tell if this strain is associated with more severe norovirus disease but likely lower population immunity is the reason for the early surge of an otherwise seasonal increase of this virus." Dr. Vinjé reiterated that "likely lower population immunity is the reason for the early surge of an otherwise seasonal increase" of the virus.

Dr. Raj Dasgupta, a board-certified physician specializing in internal medicine, critical care, pulmonology, and sleep medicine, highlighted the virus's adaptability. He remarked, "Norovirus is quite a shape-shifter," noting that increased global travel, norovirus's inherent genetic diversity, and its rapid evolution all contribute to new strains causing more frequent outbreaks. Dr. Dasgupta also suggested that "climate change might also be playing a role in outbreak patterns and where outbreaks happen."

Craig Wilen, an associate professor of laboratory medicine and immunobiology at Yale University, offered further insight into GII.17's effectiveness. He suggested that the GII.17 variant was "so effective at infecting so many people because we had significantly less immunity to that virus, since it was different enough from viruses that we've previously been infected with." This lack of prior exposure or immunity is a critical factor in the widespread impact of the new strain.

The emergence of a novel norovirus strain capable of evading widespread immunity presents a significant public health challenge. The defiance of typical seasonal patterns and the sheer volume of reported outbreaks underscore the virus's ability to adapt and spread rapidly. With experts pointing to factors like genetic diversity, increased travel, and even climate change, understanding and mitigating these outbreaks remains an ongoing priority for public health officials worldwide. The situation highlights the constant vigilance required to track and respond to evolving viral threats.